Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

OPKO Health stock price, quote, forecast and news

OPK
US68375N1037
A0MUUJ

Price

1.56
Today +/-
-0.03
Today %
-1.90 %
P

OPKO Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the OPKO Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the OPKO Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the OPKO Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze OPKO Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

OPKO Health Stock Price History

DateOPKO Health Price
9/11/20241.56 undefined
9/10/20241.59 undefined
9/9/20241.56 undefined
9/6/20241.56 undefined
9/5/20241.60 undefined
9/4/20241.62 undefined
9/3/20241.62 undefined
8/30/20241.68 undefined
8/29/20241.59 undefined
8/28/20241.65 undefined
8/27/20241.65 undefined
8/26/20241.62 undefined
8/23/20241.61 undefined
8/22/20241.61 undefined
8/21/20241.62 undefined
8/20/20241.58 undefined
8/19/20241.55 undefined
8/16/20241.55 undefined
8/15/20241.58 undefined

OPKO Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into OPKO Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OPKO Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OPKO Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of OPKO Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into OPKO Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing OPKO Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OPKO Health’s growth potential.

OPKO Health Revenue, EBIT and net profit per share

DateOPKO Health RevenueOPKO Health EBITOPKO Health Net Income
2026e750 M undefined-34.85 M undefined-89.22 M undefined
2025e721.97 M undefined-144.62 M undefined-201.92 M undefined
2024e712.27 M undefined-230.15 M undefined-212.48 M undefined
2023863.5 M undefined-157.02 M undefined-188.86 M undefined
20221 B undefined-244.9 M undefined-328.4 M undefined
20211.77 B undefined-12.7 M undefined-30.1 M undefined
20201.44 B undefined58.7 M undefined30.6 M undefined
2019901.9 M undefined-178.7 M undefined-314.9 M undefined
2018990.3 M undefined-144.5 M undefined-153 M undefined
2017966 M undefined-257.4 M undefined-305.3 M undefined
20161.12 B undefined-87.7 M undefined-48.4 M undefined
2015491.7 M undefined-98.5 M undefined-30 M undefined
201491.1 M undefined-145.8 M undefined-171.7 M undefined
201396.5 M undefined-79.6 M undefined-114.8 M undefined
201247 M undefined-37.3 M undefined-31.3 M undefined
201128 M undefined-23.2 M undefined-3.7 M undefined
201028.5 M undefined-11.1 M undefined-21.6 M undefined
20094.4 M undefined-20.1 M undefined-34.8 M undefined
20089.4 M undefined-37.2 M undefined-40.1 M undefined
2007800,000 undefined-23.4 M undefined-268.6 M undefined
20060 undefined-1.1 M undefined-900,000 undefined
20050 undefined-1.4 M undefined-400,000 undefined
20040 undefined-2.1 M undefined-2.1 M undefined

OPKO Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
000000000000000.0100.030.030.050.10.090.491.120.970.990.91.441.7710.860.710.720.75
----------------55.56600.00-67.86104.26-5.21439.56127.49-13.522.48-8.9959.2723.62-43.40-14.04-17.501.264.02
---------------25.0053.5735.7140.4348.9647.2552.1445.3035.7138.8936.5137.7032.7528.6936.85---
00000000000000011510194743256506345385329541581288318000
-2-2-3-3-3-4-8-9-8-3-2-1-1-23-37-20-11-23-37-79-145-98-87-257-144-17858-12-244-157-230-144-34
-----300.00-400.00--900.00-------411.11-500.00-39.29-82.14-78.72-82.29-159.34-19.96-7.79-26.60-14.55-19.764.04-0.68-24.30-18.19-32.30-19.97-4.53
-2-3-3-3-2-4-7-9-10-6-200-268-40-34-21-3-31-114-171-30-48-305-153-31430-30-328-188-212-201-89
-50.00---33.33100.0075.0028.5711.11-40.00-66.67----85.07-15.00-38.24-85.71933.33267.7450.00-82.4660.00535.42-49.84105.23-109.55-200.00993.33-42.6812.77-5.19-55.72
5.45.77.68.39.710.314.515.715.715.716.116.316.4128.8187.7233.2255.1280.7295.8355.1422488.1550.8559.2563.1595.5640.7648.1719.1751.77000
---------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The OPKO Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the OPKO Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (k)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
5.42.91.86.83.235.42516.110.19.98.98.623.46.742.71871.527.4185.896.9193.6168.791.596.585.572.2134.7153.295.88
0000000000001.718.811.912.521.219.820193.9220.3165.5143.9134.6286.3259.6127.3123.38
00000000000000.60.82.10.92.35.43.11529.227.418.123.116621.36.82
0000000000002.24.110.516.413.322.318.116.639.747.249.342.353.4132.386.574.165.7
0000.10.10.51.31.11.20.20.10.21.91.1191.35.513.66.311.918.115.116.927.416.4336.218.717.7
5.42.91.86.93.335.926.317.211.310.198.829.213.563.857.499.578.7242.7142.9454.1483.5348.8317.7324523.2823394.6309.48
0.10.10.10.10.30.510.200000.40.70.62.65.416.51716.4131.8122.8146.6144.7166.5178.3124121.6143.52
000000000000004.45.16.715.624.716.129.437.137.330.420.615.710.728.116.08
00001003003000000000000000000000000
0000000000000.010.010.010.010.080.10.870.861.431.411.331.251.121.070.911.020.94
0000000000001.71.15.45.939.880.5226.4224.3743.3704.6717.1700.2671.9680.6520.6595.9598.26
00000000000000.20.40.11.32.812.812.210.29.88.98.1710.19.58.79.08
0000000000000.010.010.020.020.130.211.151.122.352.282.242.131.991.951.581.771.7
0.01000.0100.040.030.020.010.010.010.010.040.020.090.080.230.291.391.272.82.772.592.452.312.472.42.172.01
                                                         
0.10.10.10.10.10.20.20.20.20.20.20.21.8228.628.727.427.54.14.35.55.65.65.96.76.76.97.87.82
0.010.010.020.020.020.070.070.070.070.070.070.070.280.310.370.380.520.571.381.532.712.852.8933.143.153.223.423.43
-9-11.9-15.1-17.8-22.2-29.4-38.1-48.5-54.3-56.2-56.4-57.1-269.3-309.1-339.2-358.4-359.7-388.8-503.2-674.8-704.9-730-1,048.9-1,197.1-1,511.1-1,481.8-1,512-1,822.9-2,011.79
00000-0.10001.100001.32.90.97.41.4-6.7-21.8-26.7-5.4-20.1-22.1-4.2-30.5-43.3-38.03
0000000000000000002-5.7-0.7-0.34.9000000
0.01000.0100.040.030.020.010.010.010.010.0200.060.050.190.210.880.851.982.091.851.791.621.671.691.561.39
0.20.30.50.50.70.61.21.210.20.30.73.32.24.86.54.910.213.48.772.553.474.347.462.5100.9826769.68
0000000000003.953.12.83.721.557.556.784.7117.1160.6133.5154.9231.7202.6107.198.87
000.10.20.30.20.10000000.30.83.61.43.19.94.377.977.961.866.819.315.828.401.38
00000000000000000000000000000
0000000.10.100002.50.14.314.78.817.51113.416.81515.340.712.427.21739.430.12
0.20.30.60.710.81.41.310.20.30.79.77.61327.618.852.391.883.1251.9263.4312288.4249.1375.6330213.5200.05
0000000.20.1000013.113.715.3005.2114.167.9109.273.7142.7172.8263.9228.6193.1226.6229.31
000000000000001.30.96.99.8166.4167.2226165.3148.7115.2118.7137.2148.5126.4126.77
1.31.21.110.90.80000000000.118.619.2146.2113.7232.3172.5142.983.562.860.24339.166.35
1.31.21.110.90.80.20.1000013.113.716.6125.534.2426.7348.8567.5411.5434.3371.5445.4426384.6392.1422.43
1.51.51.71.71.91.61.61.410.20.30.722.821.329.628.644.386.5518.5431.9819.4674.9746.3659.9694.5801.6714.6605.6622.48
0.01000.0100.040.030.020.010.010.010.010.040.020.090.080.240.31.41.282.82.772.592.452.312.472.42.172.01
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of OPKO Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand OPKO Health's financial health and stability.

Assets

OPKO Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that OPKO Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of OPKO Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into OPKO Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-2-2-2-3-2-4-7-8-10-5-100-268-39-30-18-1-29-117-174-31-48-305-153-31430-30-328-188
000000000000001023101514429610297938578108105
00000000000000000-19-1001-123-6616-3541510-740
000000000000000-2-13-1-43-3180-1948-58-68-97-204221
000000201000025215131761352861221127461126141317444
00000000000000004003642121110878
0000000000000000000114-2751-20683
-1-2-2-2-2-3-5-8-8-5-100-16-29-23-18-18-25-55-9016432-92-109-1723938-95-28
00000000000000000-2-1-4-4-15-23-46-27-12-33-32-24-16
0000000-10010010-20-22-2-14-2430-5-99-20-46-26-13-183591-18
0000000-10010010-20-22-2-12-23340-8320101568115-1
000000000000000000000000000000
1-2000000000006-20-2-43-4-17-4358-7-93-35-1123-11
09017037-10000036158109621931225821482760100
17017037-100000421281-2866183733-3561140175-35-1023-11
--------------------2.00-3.00-----7.00----
00000000000000000-40-30000000000
05-2-14-332-20-84-10023-1635-2453-44158-8896-24-775-11-136218-57
-1.7-2-2.6-2.9-2.5-3.7-5.7-8.5-8.8-5.8-1.6-0.9-0.3-17.4-29.7-23.6-19.5-20.5-26.9-59.7-95.1148.28.5-138.6-137-185.25.86.1-119.8-44.47
000000000000000000000000000000

OPKO Health stock margins

The OPKO Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OPKO Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OPKO Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the OPKO Health's sales revenue. A higher gross margin percentage indicates that the OPKO Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the OPKO Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the OPKO Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OPKO Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OPKO Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OPKO Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

OPKO Health Margin History

OPKO Health Gross marginOPKO Health Profit marginOPKO Health EBIT marginOPKO Health Profit margin
2026e36.84 %-4.65 %-11.9 %
2025e36.84 %-20.03 %-27.97 %
2024e36.84 %-32.31 %-29.83 %
202336.84 %-18.18 %-21.87 %
202228.7 %-24.39 %-32.7 %
202132.77 %-0.72 %-1.7 %
202037.69 %4.09 %2.13 %
201936.53 %-19.81 %-34.92 %
201838.94 %-14.59 %-15.45 %
201735.81 %-26.65 %-31.6 %
201645.28 %-7.85 %-4.33 %
201552.17 %-20.03 %-6.1 %
201447.31 %-160.04 %-188.47 %
201349.43 %-82.49 %-118.96 %
201240.85 %-79.36 %-66.6 %
201138.21 %-82.86 %-13.21 %
201052.63 %-38.95 %-75.79 %
200934.09 %-456.82 %-790.91 %
20089.57 %-395.74 %-426.6 %
200736.84 %-2,925 %-33,575 %
200636.84 %0 %0 %
200536.84 %0 %0 %
200436.84 %0 %0 %

OPKO Health Stock Sales Revenue, EBIT, Earnings per Share

The OPKO Health earnings per share therefore indicates how much revenue OPKO Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OPKO Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OPKO Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OPKO Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OPKO Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

OPKO Health Revenue, EBIT and net profit per share

DateOPKO Health Sales per ShareOPKO Health EBIT per shareOPKO Health Earnings per Share
2026e1.08 undefined0 undefined-0.13 undefined
2025e1.04 undefined0 undefined-0.29 undefined
2024e1.02 undefined0 undefined-0.3 undefined
20231.15 undefined-0.21 undefined-0.25 undefined
20221.4 undefined-0.34 undefined-0.46 undefined
20212.74 undefined-0.02 undefined-0.05 undefined
20202.24 undefined0.09 undefined0.05 undefined
20191.51 undefined-0.3 undefined-0.53 undefined
20181.76 undefined-0.26 undefined-0.27 undefined
20171.73 undefined-0.46 undefined-0.55 undefined
20162.03 undefined-0.16 undefined-0.09 undefined
20151.01 undefined-0.2 undefined-0.06 undefined
20140.22 undefined-0.35 undefined-0.41 undefined
20130.27 undefined-0.22 undefined-0.32 undefined
20120.16 undefined-0.13 undefined-0.11 undefined
20110.1 undefined-0.08 undefined-0.01 undefined
20100.11 undefined-0.04 undefined-0.08 undefined
20090.02 undefined-0.09 undefined-0.15 undefined
20080.05 undefined-0.2 undefined-0.21 undefined
20070.01 undefined-0.18 undefined-2.09 undefined
20060 undefined-0.07 undefined-0.05 undefined
20050 undefined-0.09 undefined-0.02 undefined
20040 undefined-0.13 undefined-0.13 undefined

OPKO Health business model

OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health is one of the most popular companies on Eulerpool.com.

OPKO Health SWOT Analysis

Strengths

1. Diverse Product Portfolio: OPKO Health Inc offers a wide range of products in the pharmaceutical and diagnostics industry, providing a diversified revenue stream.

2. Strong Research and Development: OPKO Health consistently invests in research and development activities, allowing them to innovate and introduce new products or technologies to the market.

Weaknesses

1. Regulatory Challenges: The company operates in a highly regulated industry and faces challenges in complying with various government regulations and obtaining necessary approvals.

2. Financial Dependence: OPKO Health heavily relies on external funding and partnerships for its operations, which can impact its financial stability and flexibility.

Opportunities

1. Growing Demand for Genetic Testing: With increased awareness and interest in personalized medicine, there is a growing market opportunity for OPKO Health's genetic testing products.

2. Emerging Markets Expansion: Expanding into emerging markets with large populations and underdeveloped healthcare systems presents significant growth opportunities for the company.

Threats

1. Intense Competition: The healthcare and diagnostics industry is highly competitive, with numerous established players and new entrants, which may negatively impact OPKO Health's market share and profitability.

2. Regulatory and Legal Risks: Changes in regulations, lawsuits, or legal disputes can pose significant risks to the operations and reputation of OPKO Health.

OPKO Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

OPKO Health historical P/E ratio, EBIT, and P/S ratio.

OPKO Health shares outstanding

The number of shares was OPKO Health in 2023 — This indicates how many shares 751.766 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OPKO Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OPKO Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OPKO Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OPKO Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for OPKO Health.

OPKO Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.1 -0.01  (89.58 %)2024 Q2
3/31/2024-0.1 -0.12  (-25 %)2024 Q1
12/31/2023-0.09 -0.09  (-1.24 %)2023 Q4
9/30/2023-0.1 -0.11  (-8.91 %)2023 Q3
6/30/2023-0.07 -0.03  (63.99 %)2023 Q2
3/31/2023-0.08 -0.02  (74.16 %)2023 Q1
12/31/2022-0.11 -0.11  (3.93 %)2022 Q4
9/30/2022-0.08 -0.11  (-29.72 %)2022 Q3
6/30/20220.01 -0.14  (-1,828.4 %)2022 Q2
3/31/2022-0.06 -0.08  (-41.34 %)2022 Q1
1
2
3
4
5
...
6

Eulerpool ESG Scorecard© for the OPKO Health stock

Eulerpool World ESG Rating (EESG©)

35/ 100

🌱 Environment

6

👫 Social

59

🏛️ Governance

38

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

OPKO Health list of shareholders

%
Name
Stocks
Change
Date
5.79026 % Holbrook (Bruce C)40,380,104598,9782/29/2024
5.68339 % The Vanguard Group, Inc.39,634,825428,52012/31/2023
4.75025 % Hsiao (Jane H)33,127,28402/29/2024
4.58052 % BlackRock Institutional Trust Company, N.A.31,943,6292,260,27912/31/2023
4.32005 % Frost Group, L.L.C.30,127,17702/29/2024
30.61992 % Frost Gamma Investments Trust213,537,1761,600,0003/18/2024
2.85532 % EGN 2021 Trust19,912,45954,9452/29/2024
2.85532 % GJN 2021 Trust19,912,45954,9452/29/2024
1.39370 % Geode Capital Management, L.L.C.9,719,368589,07612/31/2023
1.33452 % State Street Global Advisors (US)9,306,684-31,74412/31/2023
1
2
3
4
5
...
10

OPKO Health Executives and Management Board

Dr. Phillip Frost86
OPKO Health Chairman of the Board, Chief Executive Officer (since 2007)
Compensation 972,200
Dr. Elias Zerhouni72
OPKO Health President, Vice Chairman of the Board (since 2022)
Compensation 956,203
Dr. Jane Hsiao76
OPKO Health Vice Chairman of the Board, Chief Technical Officer (since 2007)
Compensation 912,200
Mr. Steven Rubin62
OPKO Health Executive Vice President - Administration, Director (since 2007)
Compensation 822,200
Mr. Adam Logal45
OPKO Health Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Compensation 712,200
1
2
3
4

OPKO Health Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Krystal Biotech Stock
Krystal Biotech
SupplierCustomer0,830,300,670,480,090,10
BioNano Genomics Stock
BioNano Genomics
SupplierCustomer0,660,430,880,800,410,32
MEDNAX Stock
MEDNAX
SupplierCustomer0,630,050,710,750,520,02
Eli Lilly Stock
Eli Lilly
SupplierCustomer0,490,460,07-0,17-0,22-0,39
Informa Plc Stock
Informa Plc
SupplierCustomer0,400,230,57-0,40-0,42-0,23
Sema4 Holdings A Stock
Sema4 Holdings A
SupplierCustomer0,30-0,110,740,730,36-
Pfizer Stock
Pfizer
SupplierCustomer0,14-0,16-0,090,45-0,05-0,42
Walt Disney Stock
Walt Disney
SupplierCustomer-0,34-0,520,440,510,440,11
Vifor Pharma Stock
Vifor Pharma
SupplierCustomer-0,420,04-0,62-0,38-0,41-0,41
Fresenius Medical Care Stock
Fresenius Medical Care
SupplierCustomer-0,75-0,600,26-0,33-0,040,16
1

Most common questions regarding OPKO Health

What values and corporate philosophy does OPKO Health represent?

OPKO Health Inc represents a commitment to advancing patient care and creating innovative solutions in healthcare. With a focus on precision medicine, the company strives to improve diagnostic testing and develop therapeutic treatments across various disease areas. OPKO Health Inc values scientific excellence, collaboration, and continuous innovation to enhance patient outcomes. By leveraging cutting-edge technologies and expertise, the company aims to address unmet medical needs and make a positive impact on global healthcare. Through its dedication to research and development, OPKO Health Inc is dedicated to improving the quality of life for individuals worldwide.

In which countries and regions is OPKO Health primarily present?

OPKO Health Inc is primarily present in several countries and regions. These include the United States, where the company is headquartered in Miami, Florida. Additionally, OPKO Health Inc has a significant presence in Chile, where it operates a subsidiary known as OPKO Chile. The company also has operations and partnerships in Israel, Mexico, and Ireland. With its global presence, OPKO Health Inc continues to expand its reach and make advancements in the healthcare industry across various markets.

What significant milestones has the company OPKO Health achieved?

OPKO Health Inc has achieved several significant milestones. Some of these include the FDA approval of its RECORLEV™ (levoketoconazole) drug for the treatment of endogenous Cushing's syndrome, a rare hormonal disorder. The company also received FDA approval for its RAYALDEE® (calcifediol) extended-release capsules for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease. Furthermore, OPKO Health Inc has made advancements in its diagnostics segment through the development of proprietary molecular diagnostic tests for various diseases. These achievements showcase OPKO Health Inc's commitment to innovation and improving healthcare outcomes.

What is the history and background of the company OPKO Health?

OPKO Health Inc is a biopharmaceutical and diagnostics company that focuses on developing diagnostic tests and pharmaceutical products for various medical conditions. Founded in 1991, the company has grown to become a leading player in the healthcare industry. OPKO Health Inc has a diverse portfolio of products and services, including point-of-care diagnostics, molecular diagnostics, and pharmaceuticals for the treatment of conditions such as prostate cancer, metabolic disorders, and ophthalmic diseases. With its strong emphasis on research and development, OPKO Health Inc remains committed to improving patient outcomes and providing innovative solutions in the field of healthcare.

Who are the main competitors of OPKO Health in the market?

Some of the main competitors of OPKO Health Inc in the market include companies such as AbbVie Inc, Thermo Fisher Scientific Inc, and Quest Diagnostics Incorporated.

In which industries is OPKO Health primarily active?

OPKO Health Inc primarily operates in the biotechnology and pharmaceutical industries.

What is the business model of OPKO Health?

OPKO Health Inc's business model focuses on the discovery, development, and commercialization of innovative healthcare solutions. The company operates through two main segments: Pharmaceuticals and Diagnostics. In the Pharmaceuticals segment, OPKO develops and markets a range of specialty pharmaceutical products, with a particular focus on treating chronic diseases and conditions. The Diagnostics segment involves the development and distribution of a variety of diagnostic tests and technologies across multiple therapeutic areas. Through these segments, OPKO Health Inc aims to leverage its expertise and technologies to provide better healthcare solutions to patients around the world.

What is the P/E ratio of OPKO Health 2024?

The OPKO Health P/E ratio is -5.52.

What is the P/S ratio of OPKO Health 2024?

The OPKO Health P/S ratio is 1.65.

What is the AlleAktien quality score of OPKO Health?

The AlleAktien quality score for OPKO Health is 3/10.

What is the revenue of OPKO Health 2024?

The expected OPKO Health revenue is 712.27 M USD.

How high is the profit of OPKO Health 2024?

The expected OPKO Health profit is -212.48 M USD.

What is the business model of OPKO Health

OPKO Health Inc is a diversified healthcare company focused on a wide range of diagnostic, pharmaceutical, and biotechnology products and services. The company was founded in 1991 and is headquartered in Miami, Florida. The business model of OPKO is to offer innovative diagnostic and therapeutic solutions for a variety of diseases. The company operates various business segments, including diagnostics and pharmaceuticals, biotechnology, and research and development. Diagnostics and Pharmaceuticals: OPKO is a leading provider of medical diagnostic tests, including PSA tests for prostate cancer, 4KScore for aggressive prostate cancer, and Claros 1 for rapid diagnosis of heart disease. The company also offers a wide range of pharmaceutical products for the treatment of diseases such as hemophilia, growth hormone deficiency, and low testosterone. Biotechnology: OPKO owns and operates a variety of biotechnology companies and related product lines. DemosRx produces and distributes drugs for ophthalmology and dermatology, while Bio-Reference Laboratories provides medical testing and services for physicians and clinics, supporting their patients through a wide range of pathology tests. The combination of these two diagnostic units is intended to provide hospitals with a more comprehensive second opinion in diagnosis, particularly for patients who benefit from second opinions, recognized expert opinions, or patients removed from Soliris. Research and Development: OPKO invests significant sums in research and development of new medical technologies and drugs. The company has research projects in the areas of oncology, ophthalmology, obstetrics and gynecology, neurology, and gastroenterology. Some of OPKO's key projects include the development of drugs for the treatment of Alzheimer's, autism, osteoporosis, and diabetes. OPKO Health Inc aims to offer innovative solutions to patients and medical professionals worldwide. The company builds on its position as a leading provider of diagnostic products and services and is committed to translating innovative research findings into new drugs and therapies. Overall, OPKO Health Inc is a leading provider of medical diagnostic tests, pharmaceutical products, and biotechnology solutions with the goal of improving the lives of patients worldwide.

What is the OPKO Health dividend?

OPKO Health pays a dividend of 0 USD distributed over payouts per year.

How often does OPKO Health pay dividends?

The dividend cannot currently be calculated for OPKO Health or the company does not pay out a dividend.

What is the OPKO Health ISIN?

The ISIN of OPKO Health is US68375N1037.

What is the OPKO Health WKN?

The WKN of OPKO Health is A0MUUJ.

What is the OPKO Health ticker?

The ticker of OPKO Health is OPK.

How much dividend does OPKO Health pay?

Over the past 12 months, OPKO Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OPKO Health is expected to pay a dividend of 0 USD.

What is the dividend yield of OPKO Health?

The current dividend yield of OPKO Health is .

When does OPKO Health pay dividends?

OPKO Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OPKO Health?

OPKO Health paid dividends every year for the past 0 years.

What is the dividend of OPKO Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OPKO Health located?

OPKO Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von OPKO Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OPKO Health from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did OPKO Health pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of OPKO Health in the year 2023?

In the year 2023, OPKO Health distributed 0 USD as dividends.

In which currency does OPKO Health pay out the dividend?

The dividends of OPKO Health are distributed in USD.

All fundamentals about OPKO Health

Our stock analysis for OPKO Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OPKO Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.